Analysts Offer Insights on Healthcare Companies: Applied Genetic Technologies (AGTC), Eyenovia (EYEN) and ATAI Life Sciences (ATAI)
Wells Fargo Downgrades Applied Genetic Technologies to Equalweight From Overweight, Adjusts Price Target to $0.50 From $12
Analysts Are Bullish on These Healthcare Stocks: EyePoint Pharmaceuticals (EYPT), Applied Genetic Technologies (AGTC)
Chardan Adjusts Applied Genetic Technologies Price Target to $3 From $5, Maintains Buy Rating
H.C. Wainwright Keeps Their Buy Rating on Applied Genetic Technologies (AGTC)
Wedbush Cuts Price Target on Applied Genetic Technologies to $2 From $6, Keeps Outperform Rating